Annual Drug Patent Expirations for INREBIC
Inrebic is a drug marketed by Impact and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has ninety-nine patent family members in thirty-nine countries.
The generic ingredient in INREBIC is fedratinib hydrochloride. One supplier is listed for this compound. Additional details are available on the fedratinib hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
